Maintenance fees coming due
8 maintenance fees come due in the 12 months from Nov 16, 2026, the next on Nov 19, 2026. Unpaid by May 19, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 9,034,858 | High-Strength Testosterone Undecanoate Compositions In force Fee due Nov 19, 2026 Lapses if unpaid May 19, 2027 · High confidence | Lipocine Inc. | In force | Nov 19, 2026 | May 19, 2027 | High confidence | |
| US 11,672,807 | Oral Testosterone Non-Undecanoate Therapy In force Fee due Dec 13, 2026 Lapses if unpaid Jun 14, 2027 · High confidence | Lipocine Inc. | In force | Dec 13, 2026 | Jun 14, 2027 | High confidence | |
| US 11,707,467 | (17-ß)-3-Oxoandrost-4-EN-17YL Tridecanoate Compositions and Methods of Their Preparation and Use In force Fee due Jan 25, 2027 Lapses if unpaid Jul 26, 2027 · High confidence | Lipocine Inc. | In force | Jan 25, 2027 | Jul 26, 2027 | High confidence | |
| US 9,205,057 | High-Strength Testosterone Undecanoate Compositions In force Fee due Jun 8, 2027 Lapses if unpaid Dec 8, 2027 · High confidence | Lipocine Inc. | In force | Jun 8, 2027 | Dec 8, 2027 | High confidence | |
| US 11,872,235 | Bioavailable Solid State (17-Beta)-Hydroxy-4-Androsten-3-One Esters In force Fee due Jul 16, 2027 Lapses if unpaid Jan 18, 2028 · Medium confidence | Lipocine, Inc. | In force | Jul 16, 2027 | Jan 18, 2028 | Medium confidence | |
| US 10,561,615 | Testosterone Undecanoate Compositions In force Fee due Aug 18, 2027 Lapses if unpaid Feb 18, 2028 · High confidence | Lipocine Inc. | In force | Aug 18, 2027 | Feb 18, 2028 | High confidence | |
| US 11,931,367 | Oral (17-ß)-3-Oxoandrost-4-EN-17-YL Tridecanoate Therapy In force Fee due Sep 19, 2027 Lapses if unpaid Mar 20, 2028 · High confidence | Lipocine, Inc. | In force | Sep 19, 2027 | Mar 20, 2028 | High confidence | |
| US 11,969,434 | Oral Allopregnanolone Compositions and Methods of Use In force Fee due Oct 30, 2027 Lapses if unpaid May 1, 2028 · High confidence | Lipocine, Inc. | In force | Oct 30, 2027 | May 1, 2028 | High confidence |
8 of 8 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.